HomeFBIOP • NASDAQ
add
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
Nakaraang pagsara
$8.80
Sakop ng araw
$8.60 - $9.19
Sakop ng taon
$4.72 - $17.00
Market cap
54.70M USD
Average na Volume
11.30K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.14M | 0.84% |
Gastos sa pagpapatakbo | 26.73M | 42.51% |
Net na kita | -10.58M | 31.35% |
Net profit margin | -80.55 | 31.92% |
Kita sa bawat share | -0.48 | — |
EBITDA | -21.13M | 40.28% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 91.34M | 9.03% |
Kabuuang asset | 178.07M | 8.15% |
Kabuuang sagutin | 145.58M | -13.64% |
Kabuuang equity | 32.49M | — |
Natitirang share | 29.57M | — |
Presyo para makapag-book | 11.73 | — |
Return on assets | -34.62% | — |
Return on capital | -61.64% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -10.58M | 31.35% |
Cash mula sa mga operasyon | -19.56M | 22.94% |
Cash mula sa pag-invest | 1.16M | — |
Cash mula sa financing | 52.14M | 87.16% |
Net change in cash | 33.74M | 1,265.05% |
Malayang cash flow | -8.89M | 25.15% |
Tungkol
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
Itinatag
2006
Headquarters
Website
Mga Empleyado
101
